Current status:
Cancelled Pre Market
DIN:
Not Applicable
Electronic product monograph is not available
Class:
Radiopharmaceutical
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
TETRAKIS [CU(MIBI)4]BF4
|
1 MG / VIAL
|